Coherus Biosciences | CHRS - Собственный капитал и резервы





Собственный капитал и резервы Изменить Дата
AbbVie USD -5.94B 721M 2026-06
Acadia Pharmaceuticals USD 1.31B 58.54M 2026-06
Akebia Therapeutics USD 25.02M 2.36M 2026-06
ALKERMES USD 1.81B 57.02M 2026-06
Alnylam Pharmaceuticals USD 1.35B 278.74M 2026-06
Amarin USD 443.62M 5.8M 2026-06
Amgen USD 11.69B 2.5B 2026-06
Baxter International USD 6.21B 163M 2026-06
Biogen USD 18.85B 196.3M 2026-06
BioMarin Pharmaceutical USD 6.32B 109.58M 2026-06
Bristol-Myers Squibb USD 22.32B 2.25B 2026-06
Coherus Biosciences USD 60.84M 17.78M 2026-06
Eli Lilly USD 33.88B 2.68B 2026-06
Fujifilm JPY 3.84T 119.25B 2026-03
Gilead Sciences USD 11.74B 11.77B 2026-06
Ironwood Pharmaceuticals USD -217.14M 44.69M 2026-03
Merck USD 41.93B 3.94B 2026-06
Myriad Genetics USD 303.9M 33.5M 2026-06
Pacira USD 671.98M 18.08M 2026-06
Perrigo USD 2.52B 17M 2026-06
Pfizer USD 85.19B 4.91B 2026-06
PTC Therapeutics USD -165.36M 15.1M 2026-06
Regeneron Pharmaceuticals USD 31.71B 287.8M 2026-06
Sarepta Therapeutics USD 1.53B 22.7M 2026-06
Teva Pharmaceutical Industries USD 7.75B 475M 2026-06
Vertex Pharmaceuticals USD 20.25B 886M 2026-06
Xencor USD 503.23M 12.4M 2026-06
Zoetis USD 3.15B 85M 2026-06